Company Monitoring Page for Sanofi

latest headlines for company on cafepharma

Sanofi, facing skeptical investors, predicts $5B sales for 3 drugs, names 9 more blockbusters
Fierce Biotech
Thu, 12/7/23 - 10:19 am
Tags:
Sanofi, amlitelimab, frexalimab, SAR441566
Sanofi spins up AI pact, inking $140M deal to apply Aqemia’s physics algorithms to drug discovery
Fierce Biotech
Tue, 12/5/23 - 09:57 am
Tags:
Sanofi, artificial intelligence, Aqemia, drug discovery, small molecule drugs
J&J, AbbVie, Sanofi and many other companies face competition probe in Turkey
Fierce Pharma
Sun, 12/3/23 - 09:36 pm
Tags:
JNJ, AbbVie, Sanofi, Turkey, competition
Sanofi, Regeneron eye Dupixent label expansion with promising COPD data
Medical Marketing and Media
Tue, 11/28/23 - 10:27 am
Tags:
Sanofi, Regeneron, Dupixent, clinical trials, COPD
With filing in Sanofi and Mylan insulin lawsuit, FTC amps up scrutiny on pharma's patent tactics
Fierce Pharma
Tue, 11/21/23 - 10:54 pm
Tags:
Sanofi, Mylan, legal, FTC, insulin, diabetes
Senate Democrats press Sanofi and AZ for answers as 'unprecedented' demand spurs shortage of RSV antibody Beyfortus
Fierce Pharma
Mon, 11/20/23 - 09:38 pm
Tags:
Sanofi, AstraZeneca, Senate, CDC, RSV, Beyfortus, drug shortages
Can This Pharma CEO Change The Way Drugs Are Discovered, Developed, And Delivered With AI?
Forbes
Wed, 11/8/23 - 10:16 am
Tags:
Sanofi, Paul Hudson, R&D, Pharma CEOs
Sanofi pays $30M for first look at MeiraGTx's data and a shot to brew up deals
Fierce Biotech
Tue, 10/31/23 - 09:25 pm
Tags:
Sanofi, MeiraGTx, riboswitch, drug development
Tricks and Treats as Biopharma’s Q3 Earnings Season Gets Underway
BioSpace
Sun, 10/29/23 - 08:53 pm
Tags:
earnings, Bristol Myers Squibb, Takeda, Novartis, Sanofi, Merck
Sanofi loses $21 bln in market value after dropping 2025 profit target
Reuters
Sun, 10/29/23 - 08:51 pm
Tags:
Sanofi, earnings, spinoffs, consumer health
Sanofi loses $21 bln in market value after dropping 2025 profit target
Reuters
Fri, 10/27/23 - 11:43 am
Tags:
Sanofi, Paul Hudson, Pharma CEOs
Sanofi reports setbacks to Denali, Kymab and Principia assets, delivering mix of misses and halts
Fierce Biotech
Fri, 10/27/23 - 11:36 am
Tags:
Sanofi, Denali, Kymab, Principia Biopharma
Sanofi reports positive data from Phase III trial of Dupixent
Clinical Trials Arena
Tue, 10/24/23 - 09:51 am
Tags:
Sanofi, clinical trials, Dupixent, eosinophilic esophagitis, pediatric
Dupixent returns as top Rx, OTC brand for September
Medical Marketing and Media
Tue, 10/17/23 - 09:41 pm
Tags:
Sanofi, Regeneron, Dupixent, DTC ads, pharma ads
BioMap Establishes a Strategic Collaboration with Sanofi to Co-Develop AI Modules to Accelerate Drug Discovery for Biotherapeutics
BioSpace
Tue, 10/10/23 - 11:52 am
Tags:
Sanofi, BioMap, artificial intelligence
Sanofi spin-off EuroAPI slumps as revenues falter
Pharmaphorum
Tue, 10/10/23 - 10:15 am
Tags:
Sanofi, EuroAPI, spinoffs, API
Sanofi weighs Mirati buy as KRAS cancer drug battle enters new phase
Fierce Pharma
Thu, 10/5/23 - 09:10 pm
Tags:
Mirati Therapeutics, Sanofi, M&A, KRAS inhibitors
Sanofi pays Teva $500M to join Merck, Roivant in red-hot bowel disease race
Fierce Biotech
Wed, 10/4/23 - 09:48 am
Tags:
Sanofi, Teva Pharmaceutical, inflammatory bowl disease, IBD, Merck, Roivant
Sanofi pays J&J $175M for late-phase E. coli shot, pushing deeper into vaccines as partner retreats
Fierce Biotech
Tue, 10/3/23 - 10:15 am
Tags:
Sanofi, JNJ, vaccines, E. coli
Sanofi Sells 11 CNS Assets to Pharmanovia including Frisium and Gardenal
BioSpace
Tue, 09/19/23 - 10:53 am
Tags:
Sanofi, Pharmanovia, CNS, Frisium, Gardenal

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.